Invesco

Matalan is a British fashion and homeware retailer based in Knowsley, United Kingdom.

Asia Dragon Trust is a United Kingdom‑based investment trust that seeks long‑term capital growth by investing in large, attractively priced companies across the Far East, excluding Japan and Australasia. It focuses on diversified sectors including aerospace and defense, banking, automotive, construction materials, industrial conglomerates, real‑estate management and development, and wireless telecommunications. The trust places particular emphasis on semiconductor and equipment businesses, which represent a significant portion of its revenue. Its strategy is to provide investors with access to reputable businesses in the region.

Caredoc is a platform dedicated to elderly care, designed to facilitate the connection between consumers seeking reliable care services and providers offering these services. The platform addresses the challenge of information accessibility, as families often struggle to find accurate details about elderly care facilities online or through informal channels. By providing verified information about care service providers, Caredoc enhances transparency and trust in the selection process. Additionally, it features quick matching functions and detailed caretaker profiles, allowing families to easily search for various clinics, hospitals, and doctors based on their specific needs, complete with reviews and ratings. This comprehensive approach helps streamline the search for quality elderly care, benefiting both families and care providers.

Franklin Energy Services, LLC is a company that specializes in designing and implementing customized energy efficiency programs for utilities, municipalities, and government bodies. Founded in 1989 and based in Port Washington, Wisconsin, it serves a diverse range of sectors including residential, multifamily, education, small businesses, agriculture, and commercial and industrial markets. The company provides various services such as trade ally management, rebate processing, engineering solutions, marketing, and customer care. Franklin Energy is recognized for its expertise in program administration and implementation, focusing on solutions that promote the efficient consumption of electricity and natural gas. This helps clients reduce energy consumption and achieve lower operating and maintenance costs. Franklin Energy Services was previously known as Schueller Energy Consultants before changing its name in January 1994.

Mynd is a tech-enabled property management firm specializing in single-family rental properties. It offers comprehensive solutions including marketing, tenant screening, rent collection, maintenance, accounting, and data-driven insights to optimize property performance and maximize returns for clients.

Flowcarbon is a provider of capital services focused on infrastructure and decarbonization, leveraging investment banking, project finance, tax credit, and broader financial markets expertise to help innovative companies access creative funding. The firm offers end-to-end support for asset-level transactions, including project screening and diligence, deal structuring, and financial advisory, enabling clients to navigate complex financing and engage with lenders, investors, and partners. Headquartered in New York and founded in 2021, Flowcarbon targets niche sectors by combining financial engineering with market access to streamline capital solutions for decarbonization and related infrastructure initiatives.

GeNeuro is a clinical-stage biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to the expression of pathogenic proteins derived from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody aimed at treating multiple sclerosis, while temelimab, another candidate, neutralizes a pathogenic protein associated with the HERV-W family. In addition to its therapeutic developments, GeNeuro also focuses on creating diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, GeNeuro is committed to addressing the underlying causes of neurodegenerative and autoimmune diseases.

Copper Banking is a fintech company focused on providing teens with practical financial education through its app and debit card. It offers real-time account snapshots, in-store/online shopping capabilities via Apple or Google Pay, and exclusive access to financial literacy content curated by experts.

Capchase is a fintech company founded in 2020. It operates an online platform that helps Software as a Service (SaaS) companies access cash tied up in future monthly payments, enabling them to finance their growth without dilution or expensive financing.

Swiggy is a consumer-focused technology company offering an integrated app for food ordering, grocery shopping, restaurant reservations, and event bookings. It facilitates doorstep delivery of these items via its network of on-demand delivery partners.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Pine Labs provides a merchant platform offering technology and financial solutions to help businesses increase revenue and reduce costs. It connects financial institutions and consumer brands, enabling merchants to deliver value to customers through offline and online transactions. The company's cloud-based platform powers over 350,000 POS terminals across India and Malaysia, serving more than 100,000 merchants across various sectors.

Aumni is a data-driven investment analytics platform based in the United States, focusing on private capital markets, which include venture funds, family offices, university endowments, and corporate venture firms. Founded by former corporate attorneys Tony Lewis and Kelsey Chase in Salt Lake City, Utah, Aumni leverages a combination of artificial intelligence and human expertise to extract and analyze critical deal data from complex legal agreements. The platform provides strategic insights into the economic positions and legal rights of investors, converting intricate deal data into a comprehensive and accurate dataset. By auditing and analyzing every transaction, Aumni enables investors and venture firms to make informed decisions, having already analyzed a vast array of private capital data linked to over $1 trillion in assets under management.

Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.

Mynd is a tech-enabled property management firm specializing in single-family rental properties. It offers comprehensive solutions including marketing, tenant screening, rent collection, maintenance, accounting, and data-driven insights to optimize property performance and maximize returns for clients.

Founded in 2018, Brii Biosciences is a biotechnology company dedicated to researching, developing, and commercializing medicines for chronic illnesses, with a primary focus on infectious diseases. Headquartered in Durham, North Carolina, the company operates additional offices in Shanghai and Beijing, China; and San Francisco, California.

Godrej Properties brings the Godrej Group philosophy of innovation and excellence to the real estate industry. Each Godrej Properties development combines a 119-year legacy of excellence and trust with a commitment to cutting-edge design and technology. Godrej Properties is currently developing residential, commercial and township projects spread across 10.3 million square meters (111 million square feet) in 12 cities.

Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Expert.ai is an enterprise artificial intelligence company that specializes in natural language processing and understanding, offering a platform that blends symbolic human‑like comprehension with machine learning to transform language‑intensive processes into practical knowledge. Its Cogito Discover product provides analytics, extraction, and categorization across taxonomies, enabling automation of text from formats such as XML and RDF. The company supports flexible deployment options, including on‑premise, private cloud, and public cloud, and serves industries that span insurance, banking and finance, publishing and media, defense and intelligence, and life sciences and pharma; it also delivers biomedical research solutions such as Clinical Research Navigator to aid therapy research for infectious diseases.

Clarkson PLC, established in 1852, is a global provider of integrated shipping services. It operates through four divisions: Broking, Financial, Support, and Research. The Broking segment facilitates transportation of various cargoes and handles sale and purchase transactions. The Financial segment offers investment banking services, structured finance, and freight derivatives. The Support segment provides port agency, freight forwarding, and marine supplies. The Research segment offers shipping data, analysis, and publications, serving clients in finance, government, insurance, and shipbuilding sectors. Clarkson PLC is headquartered in London, UK.

RedBlack Software develops a SaaS-based platform that empowers registered investment advisors (RIAs) of varying sizes, including family offices. Its intuitive software simplifies complex tasks, offering comprehensive rebalancing and trading capabilities alongside portfolio monitoring, compliance checks, and order management. This enables financial advisors to enhance client outcomes while streamlining operations.

Grab is a Southeast Asia-based mobile platform that integrates ride-hailing, food and grocery delivery, and financial services, connecting drivers, merchants, and customers through a single app. It operates in Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar, and holds a leading market share in ride-hailing and food delivery, with 89% of revenue derived from these core businesses. The company also offers payments, consumer loans, and enterprise financial services. It charges commissions to both riders and merchants as it links them with consumers. Founded in 2012 by Anthony Tan and Tan Hooi Ling, Grab is headquartered in Singapore and maintains offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam. In 2024, Singapore, Indonesia, and Malaysia together contributed more than 70% of revenue.

Evofem Biosciences develops and commercializes products focused on women's sexual and reproductive health. Its flagship product, Phexxi, is a hormone-free vaginal gel approved in the U.S. for pregnancy prevention.

OppenheimerFunds, Inc. is a privately owned investment manager established in 1959, based in New York City with additional offices in Rochester, London, Salt Lake City, and Centennial. The firm provides a comprehensive range of investment services, including asset management, retirement planning, mutual funds, separately managed accounts, and investment management for institutions. It serves a diverse clientele comprising financial advisors, individual investors, corporations, and endowments. OppenheimerFunds focuses on launching and managing equity, fixed income, balanced, multi-asset mutual funds, and hedge funds, employing fundamental analysis and external research to guide its investment strategies. The firm invests across public equity, fixed income, and alternative markets globally. As of May 24, 2019, OppenheimerFunds operates as a subsidiary of Invesco Ltd.

Intelliflo Ltd. is a provider of web-based business management software tailored for the financial services sector in the United Kingdom. Founded in 2004 and based in Kingston-upon-Thames, the company offers its flagship product, Intelligent Office, which serves a diverse clientele, including financial advisers, mortgage advisers, and service providers. This platform encompasses a wide range of features such as client management, financial planning, task management, compliance, and document management, enhancing operational efficiency for its users. Additionally, Intelliflo provides tools for investment research and portfolio monitoring through its FE Analytics module. The company aims to simplify the advisory experience by leveraging open software architectures and continuously evolving its technology to meet the needs of over 30,000 financial professionals worldwide, thereby supporting over three million end-investors. Through its comprehensive solutions, Intelliflo seeks to widen access to financial advice and improve the overall efficiency of financial advisory practices.

Alfred Club, Inc. is a technology-driven company that provides a resident experience and building management platform designed for apartment buildings. Founded in 2013 and based in New York, Alfred offers the Hello Alfred program, which allows residents to outsource everyday tasks such as package receiving and dog walking to dedicated home managers. These home managers are W-2 employees, ensuring they receive benefits and training, which enhances service quality and fosters local community support. The platform integrates various services, enabling residents to request assistance with grocery delivery, home cleaning, and access to exclusive events and virtual classes, all through a single, intuitive interface. Alfred has been recognized as a leader in transforming the real estate industry and has gained media attention for its innovative approach to enhancing the residential living experience.

T She Dingzhi offers a platform for clothes design. Their business enables additional, fully-customizable t-shirts, hoodies, and sweaters to its clients. Through responsible, managed services, subscription cultural apparel, and other means, they are dedicated to assisting businesses in improving their services. It adapts and pursues accuracy and exquisite, repeatedly setting the bar for the sector.

Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, established in 2006. The company specializes in the development and commercialization of medical devices and pharmaceuticals centered around Lamellasomes, a synthetic substance that imitates the function of extra-alveolar lamellar bodies. Lamellar Biomedical's innovative products target various respiratory diseases, including cystic fibrosis, and conditions such as radiotherapy-induced xerostomia and dry eye disease. The company’s therapeutic platform leverages anti-infective properties to enhance antibiotic efficacy and protect lung tissues, particularly in complex cases like idiopathic pulmonary fibrosis. Additionally, it facilitates the intracellular delivery of genetic material for pulmonary disease treatment, aiming to provide transformative therapies for severe respiratory conditions. Lamellar Biomedical was previously known as Macrocom (964) Limited before adopting its current name in February 2007.

Source is uniquely positioned to deliver highly liquid products that respond to the challenges and opportunities of the market They partner with some of the world’s largest investment houses and asset managers to create products that either offer exposure to new opportunities in the market or deliver existing strategies more effectively. They work together to ensure all of their products are efficient and transparent. On top of this, they work closely with some of the most well respected trading houses in Europe to ensure that their products are also priced as fairly as possible and are tradable throughout the day. Source is a global investment firm and one of the fastest growing European providers of exchange traded products (ETPs) By focusing on the ever-evolving needs of investors, they have grown assets under management to more than $19 billion (as at 30 July 2014) since their launch in April 2009, and during this time investors have traded more than $575 billion of Source’s products. They offer investors an efficient and transparent way to invest in equities, fixed income and commodities, as well as some alternative asset classes. Their ETPs are open-ended and domiciled in Dublin.

Glide Pharmaceutical Technologies Limited, established in 2001 and based in Abingdon, UK, is a clinical-stage company specializing in the development of solid dose formulations of therapeutics and vaccines. Its core technology, the Solid Dose Injector (SDI) system, aims to enhance patient compliance by facilitating self-administration of long-term therapies without the need for needles. Glide's pipeline includes solid dose formulations of octreotide, teriparatide, anthrax, and influenza vaccines. Additionally, the company is developing a non-invasive diagnostic technology focused on prostate cancer. Formerly known as Caretek Medical, the company changed its name to Glide Pharmaceutical Technologies Limited in 2006.

Vedanta Biosciences is a clinical-stage microbiome company focused on developing therapies for immune-mediated and infectious diseases using live bacteria derived from the human microbiome. The company designs orally delivered defined bacterial consortia, leveraging libraries of microbiome-derived strains, proprietary datasets from human interventional studies, and tools for selecting potent strains. Its platform encompasses consortium design and CGMP manufacturing of bacterially defined products, enabling physicians to access live bacteria drugs for autoimmune and inflammatory conditions. Headquartered in Cambridge, Massachusetts, Vedanta Biosciences aims to create a new category of oral therapies arising from defined bacterial communities grown from clonal cell banks.

Nexeon is an international developer and manufacturer of silicon-based anode materials for rechargeable lithium-ion batteries. The company focuses on silicon anodes to increase energy density, enabling lighter, smaller, and more cost-efficient batteries for a range of applications including electric vehicles and consumer electronics, as well as other sectors that require high-performance energy storage. Headquarters are in Oxfordshire, United Kingdom, and the company maintains operations in Japan, with a history dating back to 2006. By replacing traditional graphite anodes, Nexeon's materials aim to enhance battery performance while reducing overall carbon footprint.

Jemstep Inc. is a financial technology company based in Los Altos, California, founded in 2008. It specializes in online investment guidance and management services aimed at individual investors and financial advisors. Jemstep offers a range of services, including ratings and analysis of mutual funds and exchange-traded funds (ETFs), as well as tools for asset allocation, portfolio management, and investment research. The company also provides an automated client engagement and onboarding platform, known as Jemstep Advisor Pro, which helps investment advisors enhance their business operations by attracting prospects and improving client service. This platform integrates with various service providers to create a customizable system that supports registered investment advisors and broker-dealers in scaling their businesses effectively.

Gelesis is a biotechnology company developing therapies to treat obesity and other gastrointestinal-related chronic diseases. It specializes in mechanobiology technology, with its lead product PLENITY being an orally-administered, non-stimulant aid for weight management.

Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, established in 2006. The company specializes in the development and commercialization of medical devices and pharmaceuticals centered around Lamellasomes, a synthetic substance that imitates the function of extra-alveolar lamellar bodies. Lamellar Biomedical's innovative products target various respiratory diseases, including cystic fibrosis, and conditions such as radiotherapy-induced xerostomia and dry eye disease. The company’s therapeutic platform leverages anti-infective properties to enhance antibiotic efficacy and protect lung tissues, particularly in complex cases like idiopathic pulmonary fibrosis. Additionally, it facilitates the intracellular delivery of genetic material for pulmonary disease treatment, aiming to provide transformative therapies for severe respiratory conditions. Lamellar Biomedical was previously known as Macrocom (964) Limited before adopting its current name in February 2007.

Mereo Biopharma, established in London in 2015, specializes in acquiring and advancing late-stage drug candidates from larger pharmaceutical companies. These candidates, often overlooked due to resource constraints, target rare and specialized diseases with significant unmet medical needs. Mereo's strategy involves rapidly progressing these assets through clinical development, either by partnering or divesting them, or directly commercializing them, particularly in orphan disease indications. The company combines operational efficiency with financial resources, leveraging a unique partnership with a leading global CRO, ICON, to conduct comprehensive clinical studies. Mereo's focus is on transforming the lives of patients worldwide by developing innovative medicines that can significantly improve their quality of life.

Akamis Bio is a clinical-stage oncology company dedicated to improving cancer patient outcomes through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company develops therapeutics that enable the immune system to recognize and clear solid tumors.

SciFluor Life Sciences, Inc. is a drug discovery company based in Cambridge, Massachusetts, founded in 2011. The company focuses on developing therapeutics for various diseases, with a pipeline that includes small molecule compounds targeting neurology, ophthalmology, fibrosis, and inflammation. Notable products include SF0166, a small molecule integrin antagonist designed for topical treatment of retinal diseases such as age-related macular degeneration and diabetic macular edema, and SF0034, a KCNQ2/3 activator that serves as an anti-epileptic drug for patients with partial-onset epilepsy. SciFluor employs a late-stage fluorination technology, licensed exclusively from Harvard University, which enhances drug properties like metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. This advanced technology allows for the fluorination of a wide range of organic compounds at any stage of development.

Luminex Trading & Analytics is a company that develops an equity trading platform. This platform is designed to offer access to clean, natural block liquidity at significantly lower trading costs. By interacting exclusively with venue-approved participants, the platform ensures low-cost trading with minimal information leakage. This allows traders to execute large block trades with reduced market impact.

Founded in 2002, SpaceX designs, manufactures, and launches advanced rockets and spacecraft. Its notable projects include Falcon Heavy, Dragon, Starship, and human spaceflight initiatives.

Founded in 2014, Genomics develops algorithms and software solutions focused on cancer, microbes, and rare diseases. Its solutions empower governments, healthcare providers, pharmaceutical companies, clinicians, and researchers to improve diagnoses, treatment options, and drug development processes through accurate genomic data analysis.

Kuur Therapeutics Limited is a biopharmaceutical company focused on developing, manufacturing, and commercializing CAR-NKT cell immunotherapies for cancer treatment. The company is advancing a pipeline of immune cell products, including KUR-501 for neuroblastoma, KUR-502 for hematological malignancies, and KUR-503 for liver cancer. Kuur Therapeutics specializes in engineered off-the-shelf CAR-NKT cell therapies that leverage the natural biology of a specific subset of cytotoxic T cells known as natural killer T cells. This innovative approach aims to provide effective treatment options for a wide range of solid and hematological tumors. The company conducts clinical trials to demonstrate the efficacy of its CAR-NKT cell products, thereby striving to transform cancer care. Founded in 2005 and based in London, Kuur Therapeutics was previously known as Cell Medica Limited before its rebranding in February 2020.

Generator Hostels operates a network of budget youth hostel accommodations, founded in 1996 and based in London. The company owns and runs hostels that provide lodging for travelers, including shared and private rooms with en-suite options, and features such as communal lounges, bars and cafes. Its portfolio spans Europe and the United States, focusing on affordable, sociable stays that cater to leisure travelers seeking flexible accommodation and social experiences.

Alkermes, Inc. is an integrated biotechnology company focused on developing, manufacturing, and commercializing medicines for chronic diseases. The company specializes in therapeutic areas such as central nervous system disorders, addiction, diabetes, and autoimmune disorders. Alkermes' key products include VIVITROL, an extended-release formulation of naltrexone used for treating alcohol dependence, and RISPERDAL CONSTA, an injectable medication for schizophrenia and bipolar I disorder. The company operates a research facility in Massachusetts and a commercial manufacturing facility in Ohio. Alkermes employs its proprietary technologies to create pharmaceutical products that address unmet medical needs, and it collaborates with third-party partners to enhance its product development efforts. With a significant presence in the United States, Alkermes also extends its operations to Ireland and other international markets.

Ensurge Micropower develops ultrathin, flexible, and safe energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables powerful, lightweight, and cost-effective rechargeable energy storage for diverse uses, including hearables, sports and fitness wearables, home and industrial connected devices, and medical wearables. The company combines patented materials and process innovations with roll-to-roll manufacturing to scale production, supported by a state-of-the-art facility in Silicon Valley. With corporate headquarters in Oslo and global headquarters in San Jose, the company targets markets primarily in the United States, Europe, and Asia, reflecting strong demand for advanced, compact energy storage in wearables and connected devices.

PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.

Infirst Healthcare Ltd. is a UK-based consumer healthcare company established in 2012, specializing in the development of innovative, cocoa-flavored medicines aimed at treating cough and cold symptoms. The company focuses on enhancing well-established over-the-counter and primary care medications through proprietary solutions that can be launched within 12 to 36 months. Infirst Healthcare emerged as a spin-out from SEEK, a privately-owned drug discovery group dedicated to creating breakthrough medicines that significantly improve human health. The company is led by CEO Manfred Scheske, who has a robust background in consumer healthcare, having served as President of GSK's European and North American Consumer Healthcare business, overseeing a diverse portfolio of well-known brands.

Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.

Glide Pharmaceutical Technologies Limited, established in 2001 and based in Abingdon, UK, is a clinical-stage company specializing in the development of solid dose formulations of therapeutics and vaccines. Its core technology, the Solid Dose Injector (SDI) system, aims to enhance patient compliance by facilitating self-administration of long-term therapies without the need for needles. Glide's pipeline includes solid dose formulations of octreotide, teriparatide, anthrax, and influenza vaccines. Additionally, the company is developing a non-invasive diagnostic technology focused on prostate cancer. Formerly known as Caretek Medical, the company changed its name to Glide Pharmaceutical Technologies Limited in 2006.

Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, established in 2006. The company specializes in the development and commercialization of medical devices and pharmaceuticals centered around Lamellasomes, a synthetic substance that imitates the function of extra-alveolar lamellar bodies. Lamellar Biomedical's innovative products target various respiratory diseases, including cystic fibrosis, and conditions such as radiotherapy-induced xerostomia and dry eye disease. The company’s therapeutic platform leverages anti-infective properties to enhance antibiotic efficacy and protect lung tissues, particularly in complex cases like idiopathic pulmonary fibrosis. Additionally, it facilitates the intracellular delivery of genetic material for pulmonary disease treatment, aiming to provide transformative therapies for severe respiratory conditions. Lamellar Biomedical was previously known as Macrocom (964) Limited before adopting its current name in February 2007.

Kuur Therapeutics Limited is a biopharmaceutical company focused on developing, manufacturing, and commercializing CAR-NKT cell immunotherapies for cancer treatment. The company is advancing a pipeline of immune cell products, including KUR-501 for neuroblastoma, KUR-502 for hematological malignancies, and KUR-503 for liver cancer. Kuur Therapeutics specializes in engineered off-the-shelf CAR-NKT cell therapies that leverage the natural biology of a specific subset of cytotoxic T cells known as natural killer T cells. This innovative approach aims to provide effective treatment options for a wide range of solid and hematological tumors. The company conducts clinical trials to demonstrate the efficacy of its CAR-NKT cell products, thereby striving to transform cancer care. Founded in 2005 and based in London, Kuur Therapeutics was previously known as Cell Medica Limited before its rebranding in February 2020.

Akamis Bio is a clinical-stage oncology company dedicated to improving cancer patient outcomes through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company develops therapeutics that enable the immune system to recognize and clear solid tumors.

Oxford Immunotec is a diagnostics company specializing in the development and commercialization of proprietary tests for immunology and infectious diseases. Headquartered in the UK, with operations in the US, the company's core technology, T-SPOT, measures specific T cell responses to inform diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. Its flagship product, T-SPOT.TB, detects active and latent tuberculosis infection, while T-SPOT.CMV monitors cytomegalovirus in transplant recipients. Oxford Immunotec serves independent laboratories, hospital systems, and public and private institutions worldwide.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Spin Memory, Inc. is a technology company specializing in the development of spin-transfer torque magnetoresistive random access memory (STT-MRAM) solutions. Founded in 2007 and headquartered in Fremont, California, the company focuses on addressing the scaling and power challenges associated with conventional memory devices. Spin Memory's innovative MRAM technologies aim to replace on-chip SRAM and various non-volatile memory types in both embedded and stand-alone applications. The company's offerings promise improved performance with faster switching times, reduced power consumption, and enhanced endurance, distinguishing them from traditional memory solutions. Originally established as Spin Transfer Technologies, Inc. through a collaboration between Allied Minds and New York University, Spin Memory is positioned to lead advancements in memory technology with its unique orthogonal spin transfer MRAM approach, which facilitates smaller, more efficient devices without the limitations of endurance and data retention seen in other implementations.

Centrify Corporation specializes in unified identity management software for cloud, mobile, and data center platforms. It operates the Centrify Identity Platform, an enterprise security solution designed to protect against cyber threats and data breaches by securing access points. The company offers Identity-as-a-Service for single sign-on and security across cloud and mobile applications, privileged identity management solutions for least privilege access control, multi-factor authentication services, and a developer program. Its products cater to Fortune 500 companies, financial institutions, retailers, U.S. federal agencies, and other organizations seeking robust identity security for employees, customers, partners, IT admins, and outsourced IT. Founded in 2004, Centrify is headquartered in Santa Clara, California with additional offices in Bellevue, Washington and Murray, Utah.

Nexeon is an international developer and manufacturer of silicon-based anode materials for rechargeable lithium-ion batteries. The company focuses on silicon anodes to increase energy density, enabling lighter, smaller, and more cost-efficient batteries for a range of applications including electric vehicles and consumer electronics, as well as other sectors that require high-performance energy storage. Headquarters are in Oxfordshire, United Kingdom, and the company maintains operations in Japan, with a history dating back to 2006. By replacing traditional graphite anodes, Nexeon's materials aim to enhance battery performance while reducing overall carbon footprint.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

MaxWest Environmental Systems specializes in the development and operation of waste-to-energy gasification facilities. The company has created a technology that utilizes a gasification and heat integration process to convert various types of waste, including biosolids, agricultural residues, construction and demolition debris, waste plastics, sludge, and wood waste, into renewable energy. By transforming these carbon-based materials into green energy, MaxWest aims to address waste management challenges while contributing to sustainable energy solutions.

Akamis Bio is a clinical-stage oncology company dedicated to improving cancer patient outcomes through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company develops therapeutics that enable the immune system to recognize and clear solid tumors.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

Chelsio Communications, Inc. is a technology company based in Sunnyvale, California, specializing in high-performance networking and storage solutions. Founded in 1997, the company develops hardware and software products designed to address the challenges faced by virtualized enterprise data centers, cloud services, and cluster computing environments. Chelsio's offerings include Unified Wire Ethernet network adapter cards, unified storage software, high-performance storage gateways, and unified management software, among others. The company also produces protocol engines and server adapters that facilitate the convergence of networking and storage over Ethernet. Its products are marketed through a network of distributors, integrators, and resellers in both the United States and international markets. Chelsio maintains a design center in Bengaluru, India, to support its innovative solutions.

BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.

LogLogic is a provider of a scalable log and security intelligence platform designed for enterprises and cloud environments. The company serves over 1,300 customers, offering solutions that enable the collection and analysis of vast amounts of data generated by IT assets. LogLogic's platform equips security, IT operations, and compliance professionals with actionable insights to proactively identify issues, make informed decisions, and ensure compliance with various regulations. By managing over 1,000 petabytes of data, LogLogic enhances network stability and security, giving administrators immediate visibility into network activities and translating raw data into meaningful information.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

NovaSys Health is a prominent provider of managed healthcare services, operating one of the largest health plans in Arkansas. With approximately 11,000 contracted providers in the region and over 4,300 in Arkansas, the company emphasizes strong relationships with healthcare providers. It offers a range of health plans and related services, including customized solutions, provider relations, and eligibility and billing administration, catering to a diverse network of hospitals, physicians, and ancillary providers.

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

Touchdown Technologies, Inc. is a manufacturer specializing in advanced Micro-Electro-Mechanical Systems (MEMS) probecards, which are essential for the production wafer testing needs of semiconductor manufacturers. Founded in 2003 and based in Baldwin Park, California, the company offers innovative products such as the ACCU-TORQ probe, a torsional contactor, and GIGA-TORQ probecards specifically designed for DRAM applications. Touchdown Technologies aims to reduce the cost of wafer testing by delivering cutting-edge technologies that enhance the efficiency of highly parallel probecards. The company was previously known as Integrated Micromachines, Inc.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

Chelsio Communications, Inc. is a technology company based in Sunnyvale, California, specializing in high-performance networking and storage solutions. Founded in 1997, the company develops hardware and software products designed to address the challenges faced by virtualized enterprise data centers, cloud services, and cluster computing environments. Chelsio's offerings include Unified Wire Ethernet network adapter cards, unified storage software, high-performance storage gateways, and unified management software, among others. The company also produces protocol engines and server adapters that facilitate the convergence of networking and storage over Ethernet. Its products are marketed through a network of distributors, integrators, and resellers in both the United States and international markets. Chelsio maintains a design center in Bengaluru, India, to support its innovative solutions.

POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphereâ„¢. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphereâ„¢, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques

BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

AccountNow is a prominent provider of prepaid card financial solutions, catering to the 40 million consumers in the United States who lack established credit or traditional banking relationships. The company offers an alternative to conventional checking accounts, allowing users to access financial and payment systems through its prepaid Visa and MasterCard cards. AccountNow’s services include online bill payment, card-to-card transfers, and FDIC-insured deposits, enabling customers to deposit paychecks directly and make purchases wherever Visa debit or MasterCard is accepted. The prepaid cards are issued by The Bancorp Bank or MetaBank, ensuring secure and reliable financial services for individuals seeking accessible banking alternatives.

Antenova Ltd is a manufacturer and supplier of standard and custom antenna modules, specializing in radio frequency applications for wireless machine-to-machine (M2M), Internet of Things (IoT), and consumer electronic devices. The company offers a range of products, including gigaNOVA, RADIONOVA, ceriiANT, lamiiANT, flexiiANT, REFLECTOR, and Terminal Antennas, which cater to various applications such as WLAN, Wi-Fi, GPS, and telecoms. In addition to its antenna products, Antenova provides integration, antenna matching and testing, as well as bespoke design services and technical support. Its applications span multiple sectors, including home appliances, automotive, wearables, healthcare, industrial, retail, smart cities, and smart grid. Antenova distributes its products globally through a network of distributors and has operational centers in the United Kingdom, Taiwan, the United States, and China. Founded in 1999, the company is headquartered in Hatfield, United Kingdom.

Centrify Corporation specializes in unified identity management software for cloud, mobile, and data center platforms. It operates the Centrify Identity Platform, an enterprise security solution designed to protect against cyber threats and data breaches by securing access points. The company offers Identity-as-a-Service for single sign-on and security across cloud and mobile applications, privileged identity management solutions for least privilege access control, multi-factor authentication services, and a developer program. Its products cater to Fortune 500 companies, financial institutions, retailers, U.S. federal agencies, and other organizations seeking robust identity security for employees, customers, partners, IT admins, and outsourced IT. Founded in 2004, Centrify is headquartered in Santa Clara, California with additional offices in Bellevue, Washington and Murray, Utah.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Cortina Systems specializes in advanced communication solutions, focusing on high-speed analog-digital integration. They cater to Core, Metro, Access, and Enterprise market segments, offering products that enhance performance, density, and flexibility. By collaborating with customers to understand their system requirements, Cortina Systems facilitates faster time-to-market and increased revenue opportunities.

LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

Xenon Pharmaceuticals is a biopharmaceutical company dedicated to developing novel medicines for neurological disorders. It focuses on rare genetic defects as drug targets, leveraging its proprietary discovery platform called Extreme Genetics. The company's pipeline includes XEN1101 and XEN496 for epilepsy treatment.

Touchdown Technologies, Inc. is a manufacturer specializing in advanced Micro-Electro-Mechanical Systems (MEMS) probecards, which are essential for the production wafer testing needs of semiconductor manufacturers. Founded in 2003 and based in Baldwin Park, California, the company offers innovative products such as the ACCU-TORQ probe, a torsional contactor, and GIGA-TORQ probecards specifically designed for DRAM applications. Touchdown Technologies aims to reduce the cost of wafer testing by delivering cutting-edge technologies that enhance the efficiency of highly parallel probecards. The company was previously known as Integrated Micromachines, Inc.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Cortina Systems specializes in advanced communication solutions, focusing on high-speed analog-digital integration. They cater to Core, Metro, Access, and Enterprise market segments, offering products that enhance performance, density, and flexibility. By collaborating with customers to understand their system requirements, Cortina Systems facilitates faster time-to-market and increased revenue opportunities.

Centrify Corporation specializes in unified identity management software for cloud, mobile, and data center platforms. It operates the Centrify Identity Platform, an enterprise security solution designed to protect against cyber threats and data breaches by securing access points. The company offers Identity-as-a-Service for single sign-on and security across cloud and mobile applications, privileged identity management solutions for least privilege access control, multi-factor authentication services, and a developer program. Its products cater to Fortune 500 companies, financial institutions, retailers, U.S. federal agencies, and other organizations seeking robust identity security for employees, customers, partners, IT admins, and outsourced IT. Founded in 2004, Centrify is headquartered in Santa Clara, California with additional offices in Bellevue, Washington and Murray, Utah.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

SkyPilot Networks is a prominent provider of carrier-class broadband wireless equipment, catering to service providers, municipalities, and public safety agencies. The company specializes in enabling the rapid deployment of cost-effective network services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. Utilizing a patented multi-hop point-to-multipoint architecture, SkyPilot's solutions synchronize high-gain directional antennas to enhance reach, reduce interference, and optimize spectral efficiency. This approach results in a highly scalable and reliable broadband wireless network that simplifies design and increases deployment flexibility while significantly lowering equipment and operating costs. SkyPilot's products, such as the SkyPilot Connector Mini and Pro for long-range connectivity, as well as the SkyPilot EMS for network management, support a wide range of wireless applications. The company has successfully delivered its solutions to customers in over 50 countries and is headquartered in Santa Clara, California.

Arcot Systems, Inc. specializes in authentication and digital signing solutions aimed at protecting and verifying the digital identities of cardholders and merchants. Founded in 1997 and headquartered in Sunnyvale, California, with a technology center in Bangalore, India, the company offers a variety of services, including consumer portal protection, FFIEC compliance, identity management, Internet threat protection, SAFE biopharmaceutical compliance, and VPN authentication. Its key products include TransFort for Issuers and Merchants, RiskFort for real-time fraud prevention, WebFort and ArcotID for software-based authentication, A-OK On-Demand for secure authentication processes, and SignFort to streamline document signing and approval. Arcot Systems serves financial institutions, pharmaceutical companies, and e-commerce platforms, helping them combat online fraud and identity theft.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

Genband is a global provider of high-performance IP gateways and session border controllers, which are integral components in fixed and mobile networks worldwide. The company's products facilitate secure communication by evolving and enhancing networks' capabilities.

WhereNet Corporation specializes in wireless solutions for tracking and managing enterprise assets. Founded in 1997 and headquartered in Santa Clara, California, the company offers an integrated wireless infrastructure that supports real-time location, messaging, and telemetry applications. Its key products include WhereLAN, a cellular network of locating access points; WhereLAN LOS, a network of tag transmission receivers; and WhereTag III and IV, low-powered radio frequency transmitters and configurable asset tags, respectively. Additionally, WhereNet provides WhereCall, a wireless messaging system designed for parts replenishment in industrial manufacturing, and WherePort, which enhances the functionality of WhereTags. The company also features the Visibility Software Server, a suite of development tools for integrating its solutions with customer and third-party applications. As of 2007, WhereNet operates as a subsidiary of Zebra Technologies Corp.

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

Confluent Photonics develops DWDM optical components for telecommunications based on silicon-on-insulator semiconductor fabrication, enabling cost-effective high-volume production compatible with CMOS processes. The company designs Telcordia-compliant optical chip components for automated manufacturing of integrated optical circuits, targeting robust, environment-insensitive devices with built-in optical alignment and scalable production. Its product line includes strand-mounted DWDM nodes and DWDM Mux/Demux units, broadcast and narrowcast splitter/combiners, and rack-mounted passive DWDM modules for long-haul, metropolitan, and hybrid fiber-coax networks, as well as protection switches and passive optical modules such as filters, splitters, and taps. The approach leverages CMOS fabrication to enable potential integration of optics and electronics on a single telecommunications chip.

LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

SkyPilot Networks is a prominent provider of carrier-class broadband wireless equipment, catering to service providers, municipalities, and public safety agencies. The company specializes in enabling the rapid deployment of cost-effective network services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. Utilizing a patented multi-hop point-to-multipoint architecture, SkyPilot's solutions synchronize high-gain directional antennas to enhance reach, reduce interference, and optimize spectral efficiency. This approach results in a highly scalable and reliable broadband wireless network that simplifies design and increases deployment flexibility while significantly lowering equipment and operating costs. SkyPilot's products, such as the SkyPilot Connector Mini and Pro for long-range connectivity, as well as the SkyPilot EMS for network management, support a wide range of wireless applications. The company has successfully delivered its solutions to customers in over 50 countries and is headquartered in Santa Clara, California.

StarVox Communications is a provider of wholesale and retail voice services, specializing in both traditional voice and enhanced Voice over Internet Protocol (VoIP) offerings. The company operates a domestic VoIP network featuring multiple points of presence, enabling reliable and cost-effective connectivity for established and emerging carriers. StarVox integrates its software with industry-standard platforms, including those from major providers like Hewlett Packard and Cisco, to deliver a comprehensive, factory-integrated IP telephony solution. This solution not only unifies voice and written communication through a desktop application but also offers real-time reporting and statistics, enhancing the overall service experience for users.